Capricor Therapeutics, Inc. logo CAPR - Capricor Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 10
HOLD 0
SELL 0
STRONG
SELL
0
| PRICE TARGET: $50.88 DETAILS
HIGH: $62.00
LOW: $38.00
MEDIAN: $50.00
CONSENSUS: $50.88
UPSIDE: 76.24%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999
Revenue
Revenue 0 22.3 25.2 2.6 0.2 0.3 1.0 1.7 2.7 3.2 3.8 4.2 0.5 0.2 1.4 0 0 0 0.1 0.4 0 0 0.0 0.0 0 0 0
Cost of Revenue 0 50.0 36.4 21.8 0 0 5.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 0 (27.7) (11.3) (19.3) 0.2 0.3 (4.1) 1.7 2.7 (12.0) (8.2) (3.0) 0.5 0.2 1.4 0 0 0 0.1 0.4 0 0 0.0 0.0 0 0 0
Operating Expenses
R&D Expenses 84.5 50.0 36.4 21.8 13.6 8.5 5.1 12.1 10.8 16.0 13.8 7.8 5.2 1.0 4.1 4.1 4.5 9.5 5.1 2.7 0 0 0 0 0 0 0
SG&A Expenses 23.7 14.9 12.8 10.4 7.6 5.5 3.6 4.9 4.8 4.9 4.4 3.0 2.2 1.6 2.1 2.2 3.4 3.9 4.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0
Other Expenses 0 (50.0) (36.4) (21.8) 0 0 (5.1) 0 (10.8) (0.8) (1.7) (0.6) 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0.0
Operating Expenses 108.1 14.9 12.8 10.4 21.2 14.0 3.6 17.0 4.8 4.9 4.4 10.2 7.4 2.6 6.3 6.3 7.7 13.4 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Operating Income
Operating Income (108.1) (42.6) (24.1) (29.7) (20.9) (13.7) (7.7) (15.3) (12.9) (17.0) (12.6) (6.0) (6.9) (2.4) (4.9) (6.3) (7,883.7) (13,400.0) (9.5) (2.5) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0)
Interest Expense 3.0 0 0 0 0 0 0 0 0.4 0.3 0.2 0.2 0.1 0 0 0 0 0.0 1.1 0.0 0 0 0 0 0 0 0
Interest Income 6.3 2.2 1.7 0.5 0 0 0 0 0 0 0 0 0 0.0 0.0 0.0 0.0 0.3 0 0 0 0 0 0 0 0 0
Profitability
EBITDA (108.1) (41.1) (23.0) (29.2) (20.7) (13.5) (7.6) (15.2) 3.0 (18.3) (12.5) (6.0) (6.9) (2.4) (4.9) (6.0) (7.7) (13.0) (9.5) (2.5) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) 0.0
EBIT (108.1) (42.6) (24.1) (29.7) (20.9) (13.7) (7.7) (15.3) 2.8 (17.0) (12.6) (6.0) (6.9) (1.9) (4.9) (6.0) (7.9) (13.1) (9.5) (2.5) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) 0
Income Before Tax (105.0) (40.5) (22.3) (29.0) (20.0) (13.7) (7.6) (15.2) 2.4 (18.8) (12.9) (6.2) (8.9) (1.9) (4.9) (6.0) (7.9) (13.1) 0 0 0 (0.0) 0 0 0 0 0
Income Tax Expense 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (0.0) (0.3) 0 0 0.0 0 0 0 0 0 0.0
Net Income (105.0) (40.5) (22.3) (29.0) (20.0) (13.7) (7.6) (15.2) 2.4 (18.8) (12.9) (6.2) (8.9) (1.9) (4.9) (6.0) (7.9) (13.1) (10.3) (2.6) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0)
Per Share Data
EPS (Basic) -2.26 -1.15 -0.83 -1.18 -0.87 -0.88 -2.06 -5.17 1.00 -10.14 -8.09 -5.31 -8.47 -2.10 -65.43 -93.75 -154.56 -272.15 -304.06 -95.00 -12.49 -11.97 -10.70 -10.32 -14.77 -26.56
EPS (Diluted) -2.26 -1.15 -0.83 -1.18 -0.87 -0.88 -2.06 -5.17 0.90 -10.14 -8.09 -5.31 -8.47 -2.10 -65.43 -93.75 -154.56 -272.15 -304.06 -95.00 -12.49 -11.97 -10.70 -10.32 -14.77 -26.56
Shares Outstanding 46.5 35.2 26.8 24.6 23.1 15.6 3.7 2.9 2.3 1.9 1.6 1.2 1.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2009 2008 2004 2003 2002 2001 2000 1999
Current Assets
Cash & Cash Equivalents 287.8 11.3 14.7 9.6 34.9 32.7 3.9 4.3 6.1 3.2 3.2 5.5 0.0 0.0 0.0 0.0 0.0 0
Short-Term Investments 30.3 140.2 24.8 31.8 0 0 6.0 3.0 8.0 13.0 0 0 0 0 0 0 0 0
Net Receivables 0.1 10.4 10.4 0.5 0.4 0.1 0.1 0.2 0.3 0.2 0 0 0 0 0 0.0 0.0 0
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 0 0 0 0.9 0 (0.1) 0 0.3 0.7 1.3 0 0 0 0 0 0 0 0
Total Current Assets 322.9 163.4 50.9 42.9 36.4 33.7 10.5 8.5 15.7 18.1 3.4 6.0 0.0 0.0 0.0 0.0 0.0 0
Non-Current Assets
Property, Plant & Equipment 18.3 6.9 7.6 6.9 4.6 0.9 0.4 0.6 0.4 0.4 0.0 0.1 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0.0 0.0 0.2 0.1 0.1 0.1 0.2 0 0 0 0 0 0
Long-Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 14.7 0.2 0.3 0.3 0.3 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0 0 0 0 0.0 0.0
Total Non-Current Assets 33.0 7.1 7.9 7.2 4.9 0.9 0.6 0.8 0.6 0.6 0.2 0.4 0 0 0 0 0.0 0.0
Total Assets 355.9 170.5 58.7 50.1 41.3 34.6 11.1 9.2 16.3 18.7 3.6 6.4 0.0 0.0 0.0 0.0 0.0 0.0
Current Liabilities
Account Payables 1.7 8.2 6.2 4.8 0 2.7 0.9 1.3 1.7 3.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0
Short-Term Debt 6.4 0 0 0 0 0.2 0 0 0 0 0 0 0.1 0.0 0.0 0 0 0
Deferred Revenue 12 0 0 18.0 0 0 0 0 0 1.4 0 0 0 0 0 0 0 0
Other Current Liabilities 0 12.0 24.3 0 3.7 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0
Total Current Liabilities 35.8 21.0 31.3 23.6 4.1 3.0 0.9 1.3 1.7 4.9 0.6 1.3 0.1 0.0 0.0 0.0 0.0 0.0
Non-Current Liabilities
Long-Term Debt 0 0 0 0 0 0.1 0 0 0 13.9 0 0 0 0 0 0 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 3.4 3.4 3.4 3.4 3.4 3.4 3.4 3.4 3.9 0 0 0 0 0 0 0 0
Total Non-Current Liabilities 14.3 4.0 4.9 14.7 5.8 3.4 3.4 3.4 3.4 17.9 0 0 0 0 0 0 0 0
Total Liabilities 50.2 25.0 36.1 38.3 10.0 6.4 4.3 4.6 5.0 22.8 0.6 1.3 0.1 0.0 0.0 0.0 0.0 0.0
Stockholders' Equity
Common Stock 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Retained Earnings (304.9) (199.8) (159.4) (137.1) (108.1) (88.0) (74.4) (66.7) (51.5) (54.0) (33.9) (26.0) (0.1) (0.1) (0.1) (0.1) (0.0) (0.0)
Accumulated Other Comprehensive Income 0.3 1.0 0.2 0.1 0 0 (0.0) 0.0 0.0 0.0 0 0 0 0 0 0 0 0
Total Stockholders' Equity 305.8 145.5 22.6 11.8 31.4 28.2 6.8 4.6 11.2 (4.0) 3.0 5.1 (0.1) (0.0) (0.0) (0.0) 0.0 (0.0)
Total Liabilities & Equity 355.9 170.5 58.7 50.1 41.3 34.6 11.1 9.2 16.3 18.7 3.6 6.4 0.0 0.0 0.0 0.0 0.0 0.0
Debt Metrics
Total Debt 20.9 1.5 2.2 2.6 2.9 0.3 0 0 0 13.9 0 0 0.1 0.0 0.0 0 0 0
Net Debt (266.9) (9.8) (12.5) (7.0) (32.0) (32.3) (3.9) (4.3) (6.1) 10.7 (3.2) (5.5) 0.1 0.0 0.0 (0.0) (0.0) 0
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2005 2004 2003 2002 2001 2000 1999
Operating Activities
Net Income (105,043.9) (40.5) (22.3) (29.0) (20.0) (13.7) (7.6) (15.2) 2.4 (18.8) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0)
Depreciation & Amortization 1,889.0 1.4 1.1 0.5 0.2 0.1 0.2 0.2 0.1 0.1 0 0 0 0 0 0.0 0.0
Stock-Based Compensation 16,967.8 9.8 7.4 4.5 3.0 2.0 0.7 1.7 1.7 2.0 0 0 0 0 0 0 0
Change in Working Capital 12.2 (10.8) (11.8) 28.7 0.2 1.5 (0.1) (0.6) (2.9) (0.6) 0.0 0.0 (0.0) 0.0 0.0 0.0 (0.0)
Other Non-Cash Items 16,363.6 0.1 (0.0) 0.2 0.1 0.3 0.0 2.3 (15.7) 3.5 0 0 0 0 0 (0.0) 0.0
Operating Cash Flow (69,811.3) (40.0) (25.6) 4.9 (16.8) (10.1) (6.8) (13.9) (14.2) (15.8) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0)
Investing Activities
Capital Expenditure (2,904.5) (1.5) (2.0) (3.4) (1.2) (0.5) 0 (0.3) (0.0) (0.2) 0 0 0 0 0 0 0
Acquisitions 0 0 0 0 0 (6.0) 0 0 0 1.8 0 0 0 0 0 0 0
Purchases of Investments (151,392.4) (208.4) (97.4) (114.2) 0 (6.1) (6.0) (18.0) (19.0) (18.0) 0 0 0 0 0 0 0
Sales/Maturities of Investments 260,595.9 93.8 104.6 82.5 0 12.1 3 23 24 13 0 0 0 0 0 0 0
Other Investing Activities (8,819.7) 0 0 0 0 6.0 0 5.0 5.0 (1.8) 0 0 0 0 0 0 0
Investing Cash Flow 97,479.3 (116.2) 5.1 (35.1) (1.2) 5.4 (3.0) 4.7 5.0 (5.2) 0 0 0 0 0 0 0
Financing Activities
Net Debt Issuance 0 0 0 0 0 0.3 0 0 0.5 4.8 0 0 0.0 0.0 0 0 0
Stock Repurchased 0 0 0 0 0 0 (0.0) 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 248,643.4 0.5 0.1 0.1 0.1 5.7 0.0 0.1 0.0 0.0 0.0 0.0 (0.0) 0.0 0 0 0
Financing Cash Flow 248,892.3 152.8 25.6 4.9 20.2 33.4 9.2 6.9 11.6 18.6 0.0 0.0 0.0 0.0 0 0.1 0
Cash Position
Net Change in Cash 276,560.3 (3.4) 5.1 (25.3) 2.2 28.8 (0.6) (2.3) 2.3 (2.4) (0.0) (0.0) 0.0 (0.0) (0.0) 0.0 (0.0)
Cash at Beginning 11,287.0 14.7 9.6 34.9 32.7 3.9 4.5 6.9 4.6 5.6 0.0 0.0 0 0.0 0.0 0 0
Cash at End 287,847.3 11.3 14.7 9.6 34.9 32.7 3.9 4.5 6.9 3.2 0.0 0.0 0.0 0 0.0 0.0 (0.0)
Free Cash Flow (72,715.7) (41.5) (27.6) 1.6 (18.0) (10.6) (6.8) (14.2) (14.3) (16.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0)
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999
Income Statement
Revenue 0 22.3 25.2 2.6 0.2 0.3 1.0 1.7 2.7 3.2 3.8 4.2 0.5 0.2 1.4 0 0 0 0.1 0.4 0 0 0.0 0.0 0 0 0
Gross Profit 0 (27.7) (11.3) (19.3) 0.2 0.3 (4.1) 1.7 2.7 (12.0) (8.2) (3.0) 0.5 0.2 1.4 0 0 0 0.1 0.4 0 0 0.0 0.0 0 0 0
Operating Income (108.1) (42.6) (24.1) (29.7) (20.9) (13.7) (7.7) (15.3) (12.9) (17.0) (12.6) (6.0) (6.9) (2.4) (4.9) (6.3) (7,883.7) (13,400.0) (9.5) (2.5) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0)
Net Income (105.0) (40.5) (22.3) (29.0) (20.0) (13.7) (7.6) (15.2) 2.4 (18.8) (12.9) (6.2) (8.9) (1.9) (4.9) (6.0) (7.9) (13.1) (10.3) (2.6) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0)
EPS (Diluted) -2.26 -1.15 -0.83 -1.18 -0.87 -0.88 -2.06 -5.17 0.90 -10.14 -8.09 -5.31 -8.47 -2.10 -65.43 -93.75 -154.56 -272.15 -304.06 -95.00 -12.49 -11.97 -10.70 -10.32 -14.77 -26.56
Balance Sheet
Cash & Equivalents 287.8 11.3 14.7 9.6 34.9 32.7 3.9 4.3 6.1 3.2 3.2 5.5 0.0 0.0 0.0 0.0 0.0 0
Total Assets 355.9 170.5 58.7 50.1 41.3 34.6 11.1 9.2 16.3 18.7 3.6 6.4 0.0 0.0 0.0 0.0 0.0 0.0
Total Debt 20.9 1.5 2.2 2.6 2.9 0.3 0 0 0 13.9 0 0 0.1 0.0 0.0 0 0 0
Stockholders' Equity 305.8 145.5 22.6 11.8 31.4 28.2 6.8 4.6 11.2 (4.0) 3.0 5.1 (0.1) (0.0) (0.0) (0.0) 0.0 (0.0)
Cash Flow
Operating Cash Flow (69,811.3) (40.0) (25.6) 4.9 (16.8) (10.1) (6.8) (13.9) (14.2) (15.8) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0)
Capital Expenditure (2,904.5) (1.5) (2.0) (3.4) (1.2) (0.5) 0 (0.3) (0.0) (0.2) 0 0 0 0 0 0 0
Free Cash Flow (72,715.7) (41.5) (27.6) 1.6 (18.0) (10.6) (6.8) (14.2) (14.3) (16.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0)